Human-murine chimeric antibodies against respiratory syncytial virus
US5824307A · kind A · utility
163Cited by
3References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 15, 1994 |
| Grant date | Oct 20, 1998 |
| Priority date | — |
| Expiry date | Aug 15, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a human antibody which contains the one CDR from each variable heavy and variable light chain of at least one murine monoclonal antibody, against respiratory syncytial virus which is MAb1129 and the use thereof for the prevention and/or treatment of RSV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.